RETRACTION article

Front. Pharmacol., 08 September 2023

Sec. Ethnopharmacology

Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1289227

Retraction: Xianglian pill suppresses inflammation and protects intestinal epithelial barrier by promoting autophagy in DSS induced ulcerative colitis mice

Article metrics

View details

2,2k

Views

850

Downloads

The journal retracts the 2021 article cited above.

Following publication, concerns were raised regarding the validity of the data in the article. The authors failed to provide the raw data or a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. Given the concerns, and the lack of raw data, the editors no longer have confidence in the findings presented in the article.

This retraction was approved by the Chief Editors of Frontiers in Pharmacology and the Chief Executive Editor of Frontiers. The authors agree to this retraction.

Summary

Keywords

Xianglian pill, ulcerative colitis, Inflammation, Intestinal epithelial barrier, Autophagy

Citation

Frontiers Editorial Office (2023) Retraction: Xianglian pill suppresses inflammation and protects intestinal epithelial barrier by promoting autophagy in DSS induced ulcerative colitis mice. Front. Pharmacol. 14:1289227. doi: 10.3389/fphar.2023.1289227

Received

05 September 2023

Accepted

05 September 2023

Published

08 September 2023

Approved by

Michael Heinrich, University College London, United Kingdom

Volume

14 - 2023

Updates

Copyright

*Correspondence: Frontiers Editorial Office,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics